Document:

Unassociated Document

    Exhibit
      10.5

    

     

    April
      5,
      2006

     

    Morgan
      Joseph & Co. Inc.

    600
      Fifth
      Avenue, 19th Floor 

    New
      York,
      New York 10020

     

    Re:
      General Finance Corporation

     

    Ladies
      and Gentlemen: 

     

    This
      letter will confirm the agreement of the undersigned to purchase warrants
      (“Warrants”) of General Finance Corporation (“Company”) included in the units
      (“Units”) being sold in the Company’s initial public offering (“IPO”) upon the
      terms and conditions set forth herein. Each Unit is comprised of one share
      of
      common stock, par value $.0001 per share, of the Company (the “Common Stock”)
      and one Warrant to purchase one share of Common Stock. The shares of Common
      Stock and Warrants will not be separately tradable until 90 days after the
      effective date of the Company’s IPO unless Morgan Joseph & Co. Inc. (“Morgan
      Joseph & Co.” or the “Representative”) informs the Company of its decision
      to allow earlier separate trading.

     

    The
      undersigned agrees that on the date hereof it will enter into an agreement
      or
      plan in accordance with the guidelines specified by Rule 10b5-1 under the
      Securities Exchange Act of 1934, as amended (the “Exchange Act”), with an
      independent broker-dealer (the “Broker”) registered under Section 15 of the
      Exchange Act which is neither affiliated with the Company, the Representative
      nor part of the underwriting or selling group, pursuant to which the Broker
      will
      purchase up to $595,000 of Warrants in the public marketplace for the
      undersigned’s account during the forty-trading day period commencing on the
      later of (i) the date separate trading of the Warrants has commenced or
      (ii) 60 calendar days after the end of the restricted period under
      Regulation M, at market prices not to exceed $1.20 per Warrant (“Maximum Warrant
      Purchase”). The undersigned shall instruct the Broker to fill such order in such
      amounts and at such times as the Broker may determine, in its sole discretion,
      during the forty-trading day period described above.

     

    As
      the
      date hereof, the undersigned represents and warrants that it is not aware of
      any
      material nonpublic information concerning the Company or any securities of
      the
      Company and is entering into this agreement in good faith and not as part of
      a
      plan or scheme to evade the prohibitions of Rule 10b5-1. The undersigned
      agrees that while this agreement is in effect, the undersigned shall comply
      with
      the prohibition set forth in Rule 10b5-1(c)(1)(i)(C) against entering into
      or altering a corresponding or hedging transaction or position with respect
      to
      the Company’s securities. The undersigned further agrees that it shall not,
      directly or indirectly, communicate any material nonpublic information relating
      to the Company or the Company’s securities to any employee of the Representative
      or the Broker. The undersigned does not have, and shall not attempt to exercise,
      any influence over how, when or whether to effect purchases of Warrants pursuant
      to this agreement or the plan or agreement with the Broker.

     

    The
      undersigned shall instruct the Broker to make, keep, and produce promptly upon
      request a daily time-sequenced schedule of all Warrant purchases made pursuant
      to this agreement, on a transaction-by-transaction basis, including
      (i) size, time of execution, price of purchase; and (ii) the exchange,
      quotation system, or other facility through which the Warrant purchase
      occurred.

     

    Each
      of
      the undersigned agrees: (i) not to sell or transfer any of the Warrants
      purchased by him pursuant to this letter agreement until after the consummation
      a Business Combination (as defined in the Certificate of Incorporation of the
      Company); and (ii) the certificates for such Warrants shall contain a
      legend indicating such restriction on transferability.

     

    Kind
      regards,

     

    
      
        /s/
          Ronald F. Valenta

        Ronald
          F.
          ValentaUnassociated Document

     

    Exhibit
      10.6

    

     

    April
      5,
      2006 

     

    Morgan
      Joseph & Co. Inc.

    600
      Fifth
      Avenue, 19th Floor 

    New
      York,
      New York 10020

     

    Re:
      General Finance Corporation

     

    Ladies
      and Gentlemen: 

     

    This
      letter will confirm the agreement of the undersigned to purchase warrants
      (“Warrants”) of General Finance Corporation (“Company”) included in the units
      (“Units”) being sold in the Company’s initial public offering (“IPO”) upon the
      terms and conditions set forth herein. Each Unit is comprised of one share
      of
      common stock, par value $.0001 per share, of the Company (the “Common Stock”)
      and one Warrant to purchase one share of Common Stock. The shares of Common
      Stock and Warrants will not be separately tradable until 90 days after the
      effective date of the Company’s IPO unless Morgan Joseph & Co. Inc. (“Morgan
      Joseph & Co.” or the “Representative”) informs the Company of its decision
      to allow earlier separate trading.

     

    The
      undersigned agrees that on the date hereof it will enter into an agreement
      or
      plan in accordance with the guidelines specified by Rule 10b5-1 under the
      Securities Exchange Act of 1934, as amended (the “Exchange Act”), with an
      independent broker-dealer (the “Broker”) registered under Section 15 of the
      Exchange Act which is neither affiliated with the Company, the Representative
      nor part of the underwriting or selling group, pursuant to which the Broker
      will
      purchase up to $105,000 of Warrants in the public marketplace for the
      undersigned’s account during the forty-trading day period commencing on the
      later of (i) the date separate trading of the Warrants has commenced or
      (ii) 60 calendar days after the end of the restricted period under
      Regulation M, at market prices not to exceed $1.20 per Warrant (“Maximum Warrant
      Purchase”). The undersigned shall instruct the Broker to fill such order in such
      amounts and at such times as the Broker may determine, in its sole discretion,
      during the forty-trading day period described above.

     

    As
      the
      date hereof, the undersigned represents and warrants that it is not aware of
      any
      material nonpublic information concerning the Company or any securities of
      the
      Company and is entering into this agreement in good faith and not as part of
      a
      plan or scheme to evade the prohibitions of Rule 10b5-1. The undersigned
      agrees that while this agreement is in effect, the undersigned shall comply
      with
      the prohibition set forth in Rule 10b5-1(c)(1)(i)(C) against entering into
      or altering a corresponding or hedging transaction or position with respect
      to
      the Company’s securities. The undersigned further agrees that it shall not,
      directly or indirectly, communicate any material nonpublic information relating
      to the Company or the Company’s securities to any employee of the Representative
      or the Broker. The undersigned does not have, and shall not attempt to exercise,
      any influence over how, when or whether to effect purchases of Warrants pursuant
      to this agreement or the plan or agreement with the Broker.

     

    The
      undersigned shall instruct the Broker to make, keep, and produce promptly upon
      request a daily time-sequenced schedule of all Warrant purchases made pursuant
      to this agreement, on a transaction-by-transaction basis, including
      (i) size, time of execution, price of purchase; and (ii) the exchange,
      quotation system, or other facility through which the Warrant purchase
      occurred.

     

    Each
      of
      the undersigned agrees: (i) not to sell or transfer any of the Warrants
      purchased by him pursuant to this letter agreement until after the consummation
      a Business Combination (as defined in the Certificate of Incorporation of the
      Company); and (ii) the certificates for such Warrants shall contain a
      legend indicating such restriction on transferability.

     

    Kind
      regards,

     

    
      /s/ John O. Johnson      

      John
        O.
        JohnsonUnassociated Document

     

    Exhibit
      10.62

     

    AWARD
      AGREEMENT

     

    COLUMBIA
      LABORATORIES, INC.

     

    1996
      LONG-TERM
      PERFORMANCE
      PLAN

     

     

    This
      Award Agreement sets forth the terms and conditions of shares of Stock granted
      pursuant to the provisions of the 1996 Long-term Performance Plan (the
“Plan”)
      of
      Columbia Laboratories, Inc. (the “Company”)
      to the
      Participant whose name appears below, for the number of Shares of Stock of
      the
      Company set forth below, pursuant to the provisions of the Plan and on the
      following express terms and conditions.  Capitalized terms not otherwise
      defined herein shall have the same meanings as set forth in the
      Plan.

     

    1.
       Name
      and address of Participant to whom the Shares are granted:

     

    2.
       Number
      of Shares of Common Stock (“Shares”):

     

    3.
       Purchase
      price of Shares:

     

    $0.01
      per
      Share, the receipt of which is hereby acknowledged

     

    4.
       Date
      of grant of the Shares:

     

    5.
       Vesting.

     

    5.1 Vesting
      Schedule.
      Except
      as otherwise provided in Section 5.2, the Shares shall vest pursuant to Schedule
      1, attached hereto.  Upon any termination of service of the Participant to
      the Company, vesting of the Shares shall immediately cease and any unvested
      Shares will automatically be canceled.

     

    5.2
       Death
      of the Participant.  
      If, at any time before the Shares granted hereunder shall have vested as
      provided in Section 5.1, the Participant shall die while an employee or
      director of the Company or an
      Affiliate, the Shares immediately shall vest.

     

    5.3
       Agreement
      with respect to Tax Payments and Withholding.
      The
      Participant acknowledges and agrees that any income or other taxes due from
      the
      Participant with respect to the Shares issued pursuant to this Restricted Stock
      Award, including on account of the vesting of the Shares, shall be the
      Participant’s responsibility.  By accepting this Restricted Stock Award,
      the Participant agrees and acknowledges that (i) the Company promptly will
      withhold from the Participant’s pay the amount of taxes the Company is required
      to withhold upon any vesting of Shares pursuant to this Restricted Stock Award,
      and (ii) the Participant shall make immediate payment to the Company in the
      amount of any tax required to be withheld by the Company in excess of the
      Participant’s pay available for such withholding. The Participant may elect to
      have such withholding satisfied by a reduction of the number of shares otherwise
      so deliverable (a “Stock Withholding Election”), or by delivery of shares of
      Stock already owned by the Participant, with the amount of shares subject to
      such reduction or delivery to be calculated based on the Fair Market Value
      on
      the date of such taxable event.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

     

    6.
       Restrictions
      on Transfer. 
      The Shares may not be sold, transferred, assigned, hypothecated, pledged,
      encumbered or otherwise disposed of, whether voluntarily or by operation of
      law,
      at any time before they become vested Shares pursuant to Section 5. 
Any such purported transfer shall be null and void, and shall not be recognized
      by the Company or recorded on its books.

     

    7.
       Escrow. 
      Any Shares that have not vested pursuant to Section 5, together with any
      securities distributed in respect thereof, such as through a stock split or
      other recapitalization, shall be held by the Company in escrow until such Share
      shall have vested.  The Company promptly shall release vested Shares from
      escrow.

     

    8.
       Plan. 
      The Participant hereby acknowledges receipt of a copy of the Plan as presently
      in effect and the Prospectus with respect thereto.  All of the terms and
      provisions of the Plan are incorporated herein by reference, and this Restricted
      Stock Award is subject to those terms and provisions in all
      respects.

     

     

    

    
      	
              Participant

            	
              Columbia
                Laboratories, Inc.

            	
               

            	
               

            
	
               

            	
               

            	
               

            	
               

            
	
               

            	
               

            	
               

            	
               

            
	
              By:

            	
              By:

            	
               

            	
               

            	
               

            	
               

            
	
              Date:

            	
              Date:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00104-of-00352.parquet"}]]